We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Reckitt Benckiser PLC (PK) | USOTC:RBGLY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.17% | 11.60 | 11.50 | 11.67 | 11.6875 | 11.57 | 11.68 | 295,046 | 21:00:29 |
By Michael Susin
Reckitt Benckiser Group PLC on Thursday reported a swing to pretax loss for 2021 despite revenue on a like-for-like basis beating expectations, driven by hygiene products and a recovery in the health division.
The consumer-goods company--which houses Dettol, Harpic and Durex among its brands--posted a pretax loss of 260 million pounds ($353.2 million) for the year compared with a profit of GBP1.87 billion for 2020.
Adjusted operating profit--one of the company's preferred metrics, which strips out exceptional and other one-off items--fell to GBP2.88 billion from GBP3.30 billion the year earlier.
The company reported an operating loss of GBP804 million compared with a profit of GBP2.1 million the previous year.
Excluding the infant formula and child nutrition business in China--which the company agreed to sell to Primavera Capital in June for $2.2 billion and completed on Sept. 9--adjusted operating profit was GBP2.94 billion, matching a consensus taken from the company's website.
Revenue came in at GBP13.23 billion, down from GBP13.99 billion the prior year. Revenue was driven by strong growth in hygiene and a recovery in health, particularly in North America, as price increases were offset by a return to more normalized promotion levels, it said.
Reckitt Benckiser's health business net revenue was GBP4.65 billion and broadly flat on a like-for-like basis.
A consensus estimate taken from the company's website had forecast Reckitt's revenue at GBP13.18 billion, including IFCN China.
The company's net revenue on a like-for-like basis rose 3.5%, beating its guidance of between 1% and 3%. Excluding IFCN China, revenue was GBP12.85 billion compared with a forecast of GBP12.80 billion.
For the year ahead, the company has targeted like-for-like net revenue growth of between 1% to 4%.
"We are therefore targeting both growth in like-for-like net revenue and an increase in adjusted operating margin in 2022, despite an unprecedented inflationary environment and ongoing uncertainties created by Covid-19", Chief Executive Officer Laxman Narasimhan said.
The board declared an interim dividend of 174.6 pence, flat on the previous year, reflecting the recommendation of a final dividend of 101.6 pence.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
February 17, 2022 03:19 ET (08:19 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Reckitt Benckiser (PK) Chart |
1 Month Reckitt Benckiser (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions